Beyond Gleevec - the next generation in CML

被引：1
|
作者：
Fricker, J
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 2006年 / 42卷 / 03期
关键词：
D O I：
10.1016/j.ejca.2005.12.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：275 / 275
页数：1
相关论文
共 50 条
  • [21] Future networks - beyond next generation networking
    Marciniak, Marian
    ICTON 2008: PROCEEDINGS OF 2008 10TH ANNIVERSARY INTERNATIONAL CONFERENCE ON TRANSPARENT OPTICAL NETWORKS, VOL 1, 2008, : 25 - 28
  • [22] Advancing Digital Earth: beyond the next generation
    Ehlers, Manfred
    Woodgate, Peter
    Annoni, Alessandro
    Schade, Sven
    INTERNATIONAL JOURNAL OF DIGITAL EARTH, 2014, 7 (01) : 3 - 16
  • [23] The Desk and Beyond: Next Generation Reference Services
    Phillips, Loreen S.
    COLLEGE & RESEARCH LIBRARIES, 2009, 70 (03): : 303 - 304
  • [24] Next generation of immune checkpoint inhibitors and beyond
    Marin-Acevedo, Julian A.
    Kimbrough, ErinMarie O.
    Lou, Yanyan
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
  • [25] Differential expression-the next generation and beyond
    Auer, Paul L.
    Srivastava, Sanvesh
    Doerge, R. W.
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2012, 11 (01) : 57 - 62
  • [26] Next generation access networks: PIEMAN and beyond
    Smolorz, S.
    Rohde, H.
    Ossieur, P.
    Antony, C.
    Townsend, P. D.
    De Ridder, T.
    Baekelandt, B.
    Qiu, X. Z.
    Appathurai, S.
    Krimmel, H. -G.
    Smith, D.
    Poustie, A.
    PS: 2009 INTERNATIONAL CONFERENCE ON PHOTONICS IN SWITCHING, 2009, : 196 - +
  • [27] Beyond Next Generation Mobile Broadband: BuNGee
    Antennas, Cobham
    MICROWAVE JOURNAL, 2012, 55 (01) : 70 - +
  • [28] Dasatinib on fast track for approval by FDA for gleevec-resistant CML
    不详
    CANCER BIOLOGY & THERAPY, 2006, 5 (07) : 709 - 710
  • [29] Pancytopenia, a complication of Gleevec in treatment of accelerated and chronic phase CML.
    Zalzaleh, G
    Jajeh, A
    BLOOD, 2003, 102 (11) : 310B - 310B
  • [30] Sweet syndrome with CML cell infiltration of the skin in a chronic phase CML patient taking Gleevec.
    Liu, DL
    Seiter, K
    Mathews, T
    Madahar, C
    Ahmed, T
    BLOOD, 2002, 100 (11) : 321B - 322B
12345